Apimeds Pharmaceutical U.S, Inc.(APUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APUS Apimeds Pharmaceutical U.S, Inc.

未开盘 11-06 16:00:00 EST

2.71

-0.02

-0.92%

盘后2.70

-0.01-0.26%

19:44 EST

最高2.75	最低2.53	成交量1.67万
今开2.67	昨收2.73	日振幅8.12%
总市值408.22万	流通市值196.37万	总股本150.91万
成交额4.42万	换手率2.30%	流通股本72.59万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":2.705,"timestamp":1793998800000,"preClose":2.73,"halted":0,"volume":16685,"hourTrading":{"tag":"盘后","latestPrice":2.6979,"preClose":2.705,"latestTime":"19:44 EST","volume":1603,"amount":4321.3532,"timestamp":1794012265043,"change":-0.0071,"changeRate":-0.002625,"amplitude":0.00414},"delay":0,"changeRate":-0.009157509157509125,"floatShares":725942,"shares":1509119,"eps":-38.545,"marketStatus":"未开盘","change":-0.025,"latestTime":"11-06 16:00:00 EST","open":2.67,"high":2.7516,"low":2.53,"amount":44219.344499000006,"amplitude":0.081172,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-38.545,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":0,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":2.73,"preHourTrading":{"tag":"盘前","latestPrice":2.8048,"preClose":2.73,"latestTime":"09:09 EST","volume":14,"amount":39.0922994,"timestamp":1793974149291,"change":0.0748,"changeRate":0.027399,"amplitude":0.104139},"postHourTrading":{"tag":"盘后","latestPrice":2.6979,"preClose":2.705,"latestTime":"19:44 EST","volume":1603,"amount":4321.3532,"timestamp":1794012265043,"change":-0.0071,"changeRate":-0.002625,"amplitude":0.00414},"volumeRatio":0.519552095698356},"requestUrl":"/m/hq/s/APUS","defaultTab":"news","newsList":[{"id":"2675323688","title":"智能体长任务总“失忆”？国产开源破局，类Jev模型接管Agent调度","url":"https://stock-news.laohu8.com/highlight/detail?id=2675323688","media":"智东西","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675323688?lang=zh_cn&edition=full","pubTime":"2026-10-14 22:35","pubTimestamp":1791988541,"startTime":"0","endTime":"0","summary":"▲开源页面Reflex Agent采用MIT协议开源，提供桌面端、Web和SDK。2019年4月，该公司撤回了IPO申请。在2020年8月，APUS转向科创板再度冲击IPO，然而最终依旧终止了。APUS此次开源Reflex Agent，跳出 “大模型包揽全部决策” 的主流思路，把调度决策能力剥离出来独立建模，再依靠无损记忆体系保住任务细节。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8xE0WlFkRNZ","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["WISE","APUS","LRNZ","BK4139","EPAI","GPTZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121862226","title":"Apimeds Pharmaceuticals US董事会过渡期调整：仅保留四名成员——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1121862226","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121862226?lang=zh_cn&edition=full","pubTime":"2026-09-11 21:13","pubTimestamp":1789132390,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新提交的文件，Apimeds Pharmaceuticals US公司透露，在过渡期内其董事会成员将缩减至仅四名。市场观察人士或将对此举动的潜在意图及其对公司决策流程的影响保持关注。外界普遍推测，此举或在为更广泛的治理改革铺路，不过截至目前，官方未就成员缩减的具体原因或预计过渡期时长给出明确说明。随着更多细节浮出水面，投资者与行业分析者预计将密切关注这一发展动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157325852","title":"Apimeds Pharmaceuticals US于2026年9月10日签署和解协议第一修正案——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1157325852","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157325852?lang=zh_cn&edition=full","pubTime":"2026-09-11 21:12","pubTimestamp":1789132331,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US——这家制药公司于2026年9月10日签署了和解协议的第一修正案。相关细节已通过美国证券交易委员会（SEC）的文件正式对外披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142452397","title":"SEC文件揭示：Freet已将全部Apitox相关权利转让予Apimeds Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1142452397","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142452397?lang=zh_cn&edition=full","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"一项最新提交至美国证券交易委员会的文件显示，Apimeds Pharmaceuticals US已获得Freet方面转让的全部Apitox相关权益。这一动作意味着，围绕Apitox的所有权归属问题，如今已有了明确的界定与交接。根据该文件内容，Freet将其与Apitox相关的所有权利完整地转移给了Apimeds Pharmaceuticals。此举或将对Apimeds Pharmaceuticals未来的业务布局与产品管线产生深远影响。随着权利的正式移交，Apimeds Pharmaceuticals US如今握有更为集中的资源，未来其如何利用这一优势，值得持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111642266","title":"Apimeds Pharmaceuticals US获Apitox韩国诊所独家权利、美国25%特许权使用费及海外25%收入分成——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1111642266","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111642266?lang=zh_cn&edition=full","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件，Apimeds Pharmaceuticals US已就其核心产品Apitox达成一项重要协议。该公司获得了该产品在韩国诊所领域的100%独家权利，同时在美国市场享有25%的特许权使用费，并可参与海外市场25%的收入分成。协议条款清晰界定了各区域市场的利益分配机制——韩国市场侧重权利掌控，美国及海外市场则通过收益共享模式实现多方共赢。文件内容显示，此次权利与收益分配方案已正式确立，为Apitox的全球市场推广奠定了明确的商业框架。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apimedspharmaus.com","stockEarnings":[{"period":"1week","weight":-0.1013},{"period":"1month","weight":-0.6163},{"period":"3month","weight":-0.3605},{"period":"6month","weight":-0.8213},{"period":"1year","weight":-0.8924},{"period":"ytd","weight":-0.8351}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apimeds Pharmaceuticals US, Inc.于2020年5月11日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，正在开发Apitox，这是一种皮内注射的蜂毒毒素。他们的重点主要是开发创新疗法，解决与膝OA相关的炎症和疼痛管理症状。","exchange":"AMEX","name":"Apimeds Pharmaceutical  U.S, Inc.","nameEN":"Apimeds Pharmaceutical  U.S, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apimeds Pharmaceutical  U.S, Inc.(APUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apimeds Pharmaceutical  U.S, Inc.(APUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apimeds Pharmaceutical  U.S, Inc.,APUS,Apimeds Pharmaceutical  U.S, Inc.股票,Apimeds Pharmaceutical  U.S, Inc.股票老虎,Apimeds Pharmaceutical  U.S, Inc.股票老虎国际,Apimeds Pharmaceutical  U.S, Inc.行情,Apimeds Pharmaceutical  U.S, Inc.股票行情,Apimeds Pharmaceutical  U.S, Inc.股价,Apimeds Pharmaceutical  U.S, Inc.股市,Apimeds Pharmaceutical  U.S, Inc.股票价格,Apimeds Pharmaceutical  U.S, Inc.股票交易,Apimeds Pharmaceutical  U.S, Inc.股票购买,Apimeds Pharmaceutical  U.S, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apimeds Pharmaceutical  U.S, Inc.(APUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apimeds Pharmaceutical  U.S, Inc.(APUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}